Skye Bioscience Inc.

NASDAQ: SKYE · Real-Time Price · USD
3.50
0.17 (5.11%)
At close: Aug 20, 2025, 3:59 PM
3.46
-1.14%
After-hours: Aug 20, 2025, 07:09 PM EDT

Skye Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
11.05B -32.65M -26.57M -21.24M -42.29M -37.5M -37.64M -43.12M -21.3M -21.61M -19.48M -12.1M -10.8M -9.41M -8.52M -7.51M -6.98M -6.38M
Depreciation & Amortization
-176.6M 448.46K 298.64K 151.72K 114.51K 118.64K 124.25K 127.41K 127.43K 121.19K 115K 108.19K 86.84K 60.17K 34.13K 10.19K 3.09K 2.44K
Stock-Based Compensation
-2.19B 8.04M 8.32M 6.82M 5.06M 3.33M 987.51K 597.84K 581.76K 623.25K 629.03K 547.8K 892.65K 859.98K 869.21K 808.78K 468.17K 385.18K
Other Working Capital
2.43M -2.49M -2.04M -1.02M -2.9M -740.87K 231.98K -1.99M -1.17M -1.66M -1.56M 101.15K -254.39K -178.01K 128.31K 212.67K 127.27K -68.66K
Other Non-Cash Items
-17.9B -9.18B -6.42M -6.53M 20.96M 20.48M 23.05M 29.32M 8.18M 8.31M 6.76M 427.63K 419.58K 418K 686.66K 818.92K 805.89K 790.58K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -189.65K -189.65K -189.65K -189.65K -424.14K -397.79K
Change in Working Capital
6.26M -44.5K -869.44K -110.57K -3.55M -1.04M -469.3K -1.91M -577.07K -1.33M -761.9K 1.18M 319.53K 214.88K 646.94K -228.74K -649.13K -536.97K
Operating Cash Flow
-9.21B -9.21B -25.24M -20.91M -19.7M -14.6M -13.95M -14.98M -12.98M -13.89M -12.74M -9.84M -9.27M -8.04M -6.47M -6.29M -6.78M -6.14M
Capital Expenditures
-1.57M -7.91M -1.6M -1.56M -46.33K -13.87K -12.55K -18.04K -24.71K -27.92K -28.06K -69.59K -85.91K -82.17K -90.87K -44.06K -17.4K -17.93K
Cash Acquisitions
-1.06M -1.15M n/a 1.22M 2.22M 2.22M 1.08M 6.39M 4.95M 4.95M 4.95M -355.72K n/a n/a n/a n/a n/a n/a
Purchase of Investments
-24.75M -12.8B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
1.36M 1.36M 1.36M -5.53M -5.53M -5.53M -5.53M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-12.8B n/a n/a 5.53M 5.53M 5.53M 11.06M 5.9M 5.9M 5.82M 289.27K -80.83K -80.83K n/a n/a n/a n/a n/a
Investing Cash Flow
-12.82B -12.81B -245.62K -343.04K 2.18M 2.21M 6.6M 12.27M 10.83M 10.75M 5.21M -506.15K -166.74K -82.17K -90.87K -44.06K -17.4K -17.93K
Debt Repayment
n/a n/a n/a -22.65K 4.88M 4.75M 4.71M 4.77M -226.41K -194.84K -210.76K -244.92K -153.08K -61.23K n/a n/a n/a 566.7K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
83.56M 83.56M 83.56M n/a n/a n/a n/a n/a n/a n/a 1.97K 1.97K 7.42M 9.12M 13.16M 13.2M 11.88M 10.18M
Financial Cash Flow
23.78K -2.09M 83.56M 83.53M 100.17M 102.14M 16.44M 16.5M -226.41K -194.84K -208.79K -326.68K 7.18M 8.98M 13.08M 13.2M 11.88M 10.74M
Net Cash Flow
-22.03B -22.02B 58.08M 62.28M 82.64M 89.75M 9.09M 13.79M -2.38M -3.34M -7.74M -10.67M -2.26M 854.45K 6.51M 6.87M 5.08M 4.59M
Free Cash Flow
-34.94M -9.21B -26.84M -22.47M -19.75M -14.61M -13.96M -15M -13.01M -13.92M -12.77M -9.91M -9.36M -8.12M -6.57M -6.34M -6.8M -6.15M